4th Quarter - Amendment
NVG, LLC for ASTELLAS PHARMA US, INC.
Firm
Client
Income
$60,000
Expenses
—
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 19, 2021 | $60,000 | Replaced |
| 4th Quarter - Amendment (this page) | Jan 21, 2021 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to drug innovation; value of prescription drugs; issues related to march in rights under the Bayh-Dole Act 96-517; issues related to Medicare Part D redesign and reform.
| Lobbyist | Covered position, as disclosed |
|---|---|
| IRENE BUENO | — |
| LISA GERMAN FOSTER | — |
| EDEN SHIFERAW | — |
Defense DEF
H.R. 6395/S. 4049 - National Defense Authorization Act for Fiscal Year 2021.
| Lobbyist | Covered position, as disclosed |
|---|---|
| IRENE BUENO | — |
| LISA GERMAN FOSTER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.